Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors

Erez Marcusohn1, Ofer Kobo2, Maria Postnikov1

  • 1Department of Cardiology, Rambam Health Care Campus Haifa, Israel.

Cardiac Failure Review
|December 24, 2021
PubMed

Insights

Men with rapid heart rates during atrial fibrillation (AF) or atrial flutter (AFL) are more prone to reduced left ventricular ejection fraction (LVEF). Prosthetic valve history also increases LVEF reduction risk during AF/AFL.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiomyopathy Research

Background:

  • Atrial fibrillation (AF)-induced cardiomyopathy diagnosis is complex, requiring exclusion of other causes and assessment of left ventricular (LV) function recovery post-sinus rhythm restoration.
  • Predicting systolic dysfunction in patients with atrial tachyarrhythmia is crucial for timely intervention.

Purpose of the Study:

  • To identify clinical and echocardiographic predictors of developing cardiomyopathy with systolic dysfunction in patients experiencing atrial tachyarrhythmia.
  • To understand risk factors associated with left ventricular ejection fraction (LVEF) reduction during paroxysmal AF or atrial flutter (AFL).

Main Methods:

  • Retrospective analysis of 482 patients with baseline preserved LVEF (>50%) in sinus rhythm.
  • Comparison of patients with reduced LVEF versus preserved LVEF during precardioversion transesophageal echocardiography for AF/AFL.
  • Identification of clinical and echocardiographic parameters associated with LVEF deterioration.

Main Results:

  • 17% of patients (80/482) experienced reduced LVEF during AF/AFL.
  • Male sex and rapid ventricular response during AF/AFL were significantly associated with reduced LVEF.
  • History of prosthetic valves, tricuspid regurgitation, and right ventricular dysfunction were identified as risk factors for LVEF reduction.

Conclusions:

  • Male patients with rapid ventricular response during paroxysmal AF or AFL are at higher risk for LVEF reduction.
  • Patients with prosthetic valves are also susceptible to LVEF reduction during AF/AFL.
  • Tricuspid regurgitation and right ventricular dysfunction may suggest prolonged AF/AFL with associated LVEF decline.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
43
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
73
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
96
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
78
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
109
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
77